Predictors of Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection in Hong Kong

被引:60
|
作者
Mak, So Shan [1 ]
Yeo, Winnie
Lee, Yik Mun [1 ]
Mo, Kwok Fai [2 ]
Tse, Ka Yin [2 ]
Tse, Sut Mun [1 ]
Ho, Fung Ping [1 ]
Kwan, Wing Hong [1 ]
机构
[1] Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Clin Oncol, Comprehens Canc Trials Unit, Shatin, Hong Kong, Peoples R China
关键词
breast cancer; case-control study; lymphedema; risk factor; treatment-related complication;
D O I
10.1097/NNR.0b013e31818c3de2
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background. The incidence rate of breast cancer is rising rapidly in Hong Kong. Lymphedema is a serious long-term complication of breast cancer surgery and radiation therapy. Objective: The objectives of this study were to evaluate risk factors associated with the development of lymphedema for patients with breast cancer who have had an axillary lymph node dissection and to explore potential factors associated with moderate to severe lymphedema. Methods: This was a matched case-control study of 202 women undergoing a unilateral axillary dissection for breast cancer, consisting of 101 cases with lymphedema and 101 controls who matched cases in terms of surgery date, axillary radiotherapy, and cancer stage. Arm circumferences were measured to determine presence and severity of lymphedema. Potential risk factors were collected by using clinical data and a questionnaire. A multiple logistic regression was used to obtain the adjusted odds ratios for potential risk factors for developing lymphedema. Exploratory analysis was also performed to identify factors associated with the development of moderate to severe lymphedema. Results: Adjusted odds ratios for the development of lymphedema were 3.80 (95% confidence interval [CI] 1.84-7.87) for previous inflammation-infection and 1.06 (95% CI = 1.02-1.10) for an increase of 1 year of age at axillary dissection. On exploratory analysis, adjusted odds ratios for moderate to severe degree of lymphedema were 4.53 (95% CI = 2.16-9.52) for previous inflammation-infection, 2.94 (95% CI = 1.44-6.03) for operation on dominant arm, 1.11 (95% CI 1.01-1.22) for an increase of I kg/m(2) in body mass index (BMI) at recruitment, and 1.05 (95% CI = 1.01-1.10) for an increase of 1 year of age at recruitment time. Discussion: Previous inflammation-infection and advanced age at axillary dissection are risk factors associated with the initiation of lymphedema. Previous inflammation-infection, operation on the side of the dominant hand, obesity, and aging are potential risk factors associated with the aggravation of lymphedema. Greater BMI is still a risk factor for lymphedema progression even in a lower BMI population.
引用
收藏
页码:418 / 427
页数:10
相关论文
共 50 条
  • [31] Physiotherapeutic stimulation: Early prevention of lymphedema following axillary lymph node dissection for breast cancer treatment
    Sarri, Almir Jose
    Moriguchi, Sonia Marta
    Dias, Rogerio
    Peres, Stela Verzinhasse
    Da Silva, Eduardo Tinois
    Koga, Katia Hiromoto
    Zucca Matthes, Angelo Gustavo
    Dos Santos, Marcelo Jose
    Da Rocha, Euclides Timoteo
    Haikel, Raphael Luiz
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (01) : 147 - 152
  • [32] Prediction of the probability of breast cancer-related lymphedema after axillary lymph node dissection.
    Soran, Atilla
    Ibrahim, Ahmad
    DeGore, Lori
    Johnson, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [33] Axillary reverse mapping for preventing lymphedema in axillary lymph node dissection and/or sentinel lymph node biopsy
    Noguchi, Masakuni
    BREAST CANCER, 2010, 17 (03) : 155 - 157
  • [34] Axillary reverse mapping for preventing lymphedema in axillary lymph node dissection and/or sentinel lymph node biopsy
    Masakuni Noguchi
    Breast Cancer, 2010, 17 : 155 - 157
  • [35] Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients
    Schrenk, P
    Shamiyeh, A
    Wayand, W
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (04): : 378 - 382
  • [36] Is axillary dissection necessary for breast cancer patients with micrometastasis in the sentinel lymph node?
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 80 - 80
  • [37] Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer
    Collins, Madison
    O'Donoghue, Cristina
    Sun, Weihong
    Zhou, Jun-min
    Ma, Zhenjun
    Laronga, Christine
    Lee, Marie Catherine
    JOURNAL OF SURGICAL RESEARCH, 2017, 215 : 55 - 59
  • [38] Role of tranexamic acid in axillary lymph node dissection in breast cancer patients
    Lohani, Kush Raj
    Kumar, Chitresh
    Kataria, Kamal
    Srivastava, Anurag
    Ranjan, Piyush
    Dhar, Anita
    BREAST JOURNAL, 2020, 26 (07): : 1316 - 1320
  • [40] Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer - Discussion
    McMasters, K
    Velasco, JM
    Winchester, D
    Robinson, DS
    Goodnight, JE
    Organ, CH
    ARCHIVES OF SURGERY, 2003, 138 (05) : 487 - 488